XML 183 R134.htm IDEA: XBRL DOCUMENT v3.3.1.900
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders - Basic and Diluted Numerator and Denominator (Detail) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
EPS Numerator-Basic      
Income from continuing operations [1] $ 6,975 $ 9,119 $ 11,410
Less: Net income attributable to noncontrolling interests 26 32 30
Income from continuing operations attributable to Pfizer Inc. 6,949 9,087 11,380
Less: Preferred stock dividends––net of tax 1 1 2
Income from continuing operations attributable to Pfizer Inc. common shareholders 6,948 9,086 11,378
Discontinued operations––net of tax [1],[2] 11 48 10,662
Less: Discontinued operations––net of tax, attributable to noncontrolling interests 0 0 39
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders 11 48 10,623
Net income attributable to Pfizer Inc. common shareholders 6,959 9,134 22,001
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions 6,948 9,087 11,380
Net income attributable to Pfizer Inc. common shareholders and assumed conversions $ 6,960 $ 9,135 $ 22,003
EPS Denominator      
Weighted-average number of common shares outstanding––Basic [1] 6,176 6,346 6,813
Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreement 81 78 82
Weighted-average number of common shares outstanding––Diluted [1] 6,257 6,424 6,895
Equity Option [Member]      
EPS Denominator      
Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans [3] 50 44 43
[1] Amounts may not add due to rounding.
[2] Includes the Animal Health (Zoetis) business through June 24, 2013, the date of disposal.
[3] These common stock equivalents were outstanding for the years ended December 31, 2015, 2014 and 2013, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.